Search

Author/Creator de Bruyn, M

2. P010 Serum proteomic profiling in Crohn's disease patients undergoing ileocolonic resection reveals discriminative inflammatory markers for endoscopic recurrence. (16th January 2018)

Authors:
Machiels, K; de Bruyn, M; Verstockt, S; Verstockt, B; Van Assche, G; Wolthuis, A; d'Hoore, A; Ferrante, M; Vermeire, S
Journal:
Journal of Crohn's and colitis
Issue:
Volume 12:Number 1(2018:Jan.)Supplement 1
Page Start:
S096
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P042 Decreased leukocyte trafficking may contribute to vedolizumab refractory disease after anti-TNF exposure in patients with ulcerative colitis. (16th January 2018)

Authors:
Verstockt, B; Verstockt, S; de Bruyn, M; Machiels, K; Blevi, H; Ballet, V; Van Assche, G; Vermeire, S; Ferrante, M
Journal:
Journal of Crohn's and colitis
Issue:
Volume 12:Number 1(2018:Jan.)Supplement 1
Page Start:
S113
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Prognostic relevance of the molecular classification in high-risk endometrial cancer: analysis of the PORTEC-3 trial. (1st November 2019)

Authors:
Leon-Castillo, A; de Boer, SM; Powell, ME; Mileshkin, LR; Mackay, HJ; Leary, A; Nijman, HW; Singh, N; Pollock, P; Bessette, P; Haie-Meder, C; Smit, VTHBM; Edmondson, RJ; Putter, H; Kitchener, HC; Crosbie, EJ; de Bruyn, M; Nout, RA; Horeweg, N; Bosse, T
Journal:
International journal of gynecological cancer
Issue:
Volume 29(2019)Supplement 4
Page Start:
A7
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗